These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20737807)

  • 21. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.
    Pomey MP; Forest PG; Palley HA; Martin E
    Milbank Q; 2007 Sep; 85(3):469-98. PubMed ID: 17718665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR; Pauly MV
    Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
    Mendoza RL
    J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Essential drugs and pharmaceutical care: reflection on the access to drugs through lawsuits in Brazil].
    Sant'ana JM; Pepe VL; Osorio-de-Castro CG; Ventura M
    Rev Panam Salud Publica; 2011 Feb; 29(2):138-44. PubMed ID: 21437372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian drug policy: ethical aims of essential assistance levels.
    Bernardi A; Pegoraro R
    Health Care Anal; 2003 Dec; 11(4):279-86. PubMed ID: 14769009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System.
    Yoo SL; Kim DJ; Lee SM; Kang WG; Kim SY; Lee JH; Suh DC
    Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30669602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 30. Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.
    Moon S; Erickson E
    N Engl J Med; 2019 Feb; 380(7):607-610. PubMed ID: 30763190
    [No Abstract]   [Full Text] [Related]  

  • 31. Solidarity, justice and unconditional access to healthcare.
    Gheaus A
    J Med Ethics; 2017 Mar; 43(3):177-181. PubMed ID: 27354245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug reimbursement policies in Canada--need for improved access to critical therapies.
    LeLorier J; Bell A; Bougher DJ; Cox JL; Turpie AG
    Ann Pharmacother; 2008 Jun; 42(6):869-73. PubMed ID: 18477735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicaid formularies: a critical review of the literature.
    Jang R
    J Pharm Mark Manage; 1988; 2(3):39-61. PubMed ID: 10302873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand.
    Rawson NSB
    J Popul Ther Clin Pharmacol; 2020 Jun; 27(2):e58-e67. PubMed ID: 32543163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating philosophy, policy and practice to create a just and fair health service.
    Fritz Z; Cox CL
    J Med Ethics; 2020 Dec; 46(12):797-802. PubMed ID: 33028624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tick-off-formularies concerning single subsidy of certain drugs--with implemented criteria].
    Ugeskr Laeger; 2002 Dec; 164(51):6094-5. PubMed ID: 12553155
    [No Abstract]   [Full Text] [Related]  

  • 40. Consumers face higher costs as health plans seek to control drug spending.
    Mays GP; Hurley RE; Grossman JM
    Issue Brief Cent Stud Health Syst Change; 2001 Nov; (45):1-4. PubMed ID: 11865903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.